A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab

We investigated whether microRNA expression data from glioblastoma could be used to produce a profile that defines a bevacizumab responsive group of patients.

Source: Molecular Oncology - June 30, 2016 Category: Cancer & Oncology Authors: Josie Hayes, Helene Thygesen, Walter Gregory, David R. Westhead, Pim J. French, Martin J. Van Den Bent, Sean E. Lawler, Susan C. Short Source Type: research